The tumor volumes were calculated from MRI data and a dose dependent effect on tumor size for anti-YKL-40 could be observed (probably due to the low animal number, however, not statistically significant: P = 0.199, two way ANOVA; Figure 5C). The gene discussed is CHI3L1; the disease is neoplasm.